Optimization of Lovastatin production under sub-merged fermentation and its effect on cholesterol blood level in rats
DOI:
https://doi.org/10.56511/JIPBS.2016.v3.i04.pp33-42Abstract
Lovastatin was endorsed for the treatment of hypercholesterolemia. In the current work, culture parameters (temperature, initial pH, incubation period, and carbon & nitrogen sources) were optimized for lovastatin production by Aspergillus fumigatus. Different concentrations of glucose and peptone had been also examined that enhances lovastatin production by Aspergillus fumigatus. The lovastatin yield of (0.869 mg/ml) was obtained at an optimum temperature of 30˚C; pH of 6; glucose concentration 35g/l; peptone concentration 7.769 g/l and at an incubation period of 10 days. Impact of produced lovastatin, had been examined on an experimental model of hypercholesterolemic rats that was established by feeding normolipidemic diet (NLD) supplemented with 4% cholesterol, 1% cholic acid and 0.5% thiouracil, w/w for three months. Current study uncovered that hypercholesterolemic rats recorded a significant elevation in total lipids (TL), total cholesterol (TC), triglycerides (TG), low density lipoprotein cholesterol (LDL-C), very low density lipoprotein cholesterol (VLDL-C) and phospholipids (PL), whereas high density lipoprotein cholesterol (HDL-C) was decreased. In comparison the produced lovastatin instigated noteworthy decline in serum TL, PL, TC, TG, LDL-C, VLDL-C levels. On other hand, lovastatin treatment to hypercholesterolemic rats improved the lipid profile in hepatic tissues. In addition, lovastatin treatment expanded hepatic enzyme levels AST and ALT compared to Hypercholesterolemic rats. Meanwhile there was a significant decrease in lipid peroxidation alongside with significant elevation of total antioxidant (TAO) as SOD, CAT and GSH in the liver. Bringing down of these parameters, may in charge of both lipid-bringing down and antioxidative action of lovastatin, which shield liver from hyperchlorestrimia.
Keywords:
lovastatin, Aspergillus fumigates, hypercholesterolemia, antioxidant enzymes, ratsDownloads
References
Csaba C. et al.: Modulation of Hypercholesterolemia-Induced Oxidative/Nitrative Stress in the Heart. Oxidative Medicine and Cellular Longevity 2016; Article ID 3863726, 23 pages.
Seenivasana A, Sathyanarayana N. Gummadib, Tapobrata P. and Thomas T: Quantification of lovastatin produced by Monascus purpureus. The Open Biotechnology Journal 2015; 9:6-13.
Mishal S, Rani Faryal and Ian M: Exploitation of Aspergillus terreus for the production of Natural Statins J. Fungi 2016; 2:113.
Rashmi D., Padmavathi T: Statistical optimization of lovastatin and confirmation of nonexistence of citrinin under solid-state fermentation by Monascus sanguineus. Journal of food and drug analysis 2016; 24:430 - 440.
Kallas K. , Annika T. and Toivo M: Lovastatin Decreases the Expression of CD133 and Influences the Differentiation Potential of Human Embryonic Stem Cells 2016; Article ID 1580701, 16 pages.
Prasanna Latha D and Hemalatha K: Production of lovastatin by Aspergillus fischeri NCIM 509 using barley bran, wheat husk, rice bran and rice husk under solid state fermentation. European Journal of Experimental Biology 2015; 5(8):8-17.
Praveen VK, Savitha J: Solid state fermentation: an effective method for lovastatin production by fungi over submerged fermentation. E3 Journal of Biotech Pharma Res 2012; 3(2):15-21.
Bizukojc M, Ledakowicz S: A macrokinetic modelling of the biosynthesis of lovastatin by Aspergillus terreus. J Biotechnol 2007; 130(4):422 – 35.
Upendra RS, Khandelwal Pratima, Amiri ZR, Shwetha L, Ausim M: Screening and molecular characterization of natural fungal isolates producing lovastatin. Microbial Biochem Tech 2013; 5(2):025-30.
Praveen V, et al.: Optimization of Culture Conditions for Maximal Lovastatin Production by Aspergillus terreus (KM017963) under Solid State Fermentation. Journal of Bioscience 2016; 22:174-180.
Burcu A, Yamaç Mustafa, Zeki Y, Isikhuemhen Omoanghe S: Statistical optimization of lovastatin production by Omphalotus olearius (DC.) singer in submerged fermentation. Preparative Biochemistry & Biotechnology 2016; 46(3):254-260.
Srinu M., et al.: Screening of HMG CoA reduc-tase inhibitor producing marine actinomycetes. J. Pharm. Sci. Health 2010; 2(1):66-74.
Kelly CL M., et al.: Lovastatin production: From molecular basis to industrial process optimization. Biotechnology Advances 2015; 33:648 – 665.
Sreenivasan A, Shubahgar S, Arvindan R, Viruthagiri T: Microbial production and biomedical applications of lovastatin. Indian J Pharm Sci. 2008; 70:701-709.
Tandon V, Bano, G, Khajuria V, Parihar A, Gupta S: Pleiotropic effects of statins. Ind J Pharmacol 2005; 37:77-85.
Barrios GJ, Miranda RU: Biotechnological production and applications of statins. Appl. Microbiol. Biotech. 2010; 85:869-883.
Glynn SA, O'Sullivan D, Eustace AJ, Clynes M, O'Donovan N: The 3hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors, simvastatin, lovastatin and mevastatin inhibit proliferation and invasion of melanoma cells. BMC Cancer 2008; 16:8-9.
Carrie, et al.: A randomized placebo-controlled lovastatin trial for neurobehavioral function in neurofibromatosis. Annals of Clinical and Translational Neurology 2016; 3(4):266 – 279.
Radha KV, Lakshmanan D: A review: lovastatin production and applications. Asian J Pharma Clincal Res 2013; 6(3):21-26.
Garrett IR., et al.: Locally delivered lovastatin nanoparticles enhance fracture healing in rats. J. Ortho. Res. 2007; 25(10):1351-1357.
László Galgóczy, Ildikó Nyilasi, Tamás Papp, Csaba V: Statins as antifungal agents. World J Clin Infect Dis 2011; 1(1):4-10.
Zhuge B, Fang HY, Yu H, et al.: Bioconversion of lovastatin to a novel statin by Amycolatopsis sp. Appl Microbiol Biotechnol 2008; 79: 209216.
Nigovi B, Pavkovi I: Preconcentration of the lipid-lowering drug lovastatin at a hanging mercury drop electrode surface. J Anal Chem 2009; 64:304-309.
Mouafi, F. E., Ghada S.I. and Mostafa M. A: Screening and optimization of Lovastatin Production by isolated Aspergillus fumigatus under solid state fermentation. Journal of Genetic Engineering and Biotechnology (accepted 17 October) 2016; Number: JGEB-D-15-00058
Sayyad S. A., Bibhu P. P., Saleem J. and Mohd A: Optimization of nutrient parameters for lovastatin p roduction by Monascus purpureus MTCC 369 under submerged fermentation using response surface methodology. Appl Microbiol Biotechnol 2007; 73:1054 – 1058.
Raghunath R., Radhakrishna A., Angayarkanni J., Palaniswamy M.: Production and cytotoxicity studies of Lovastatin from Aspergillus niger PN2 an endophytic fungi isolated from Taxus baccata. IJABPT 2012; 3:562-570.
Mielcarek J., Naskreni M., Grobelny P: Photochemical properties of simvastatin and lovastatin by radiation. J Thermal Analysis Calorimetry 2009; 96:301-305.
Ouda SM, et al.: Optimization of Different Parameters on Lovastatin Production by Aspergillus niger I4 and Aspergillus terreus I8 and its Hypocholesterolemic Effect. R. J. Ph. Biol. and Ch. Sci. 2015; 6(5):1439-1448.
EL-Wakf, M.A., Ibrahim, H.A., Hassan, H.A., Serag, H.M., Gumaih, H.S: Favorable Alteration Of Cardiovascular Disorders With Virgin Olive Oil Compared To Refined Olive Oil In Atherosclerotic Male Rats. J. Egypt. Ger. Soc. Zool. 2010; 61(A):25-47.
Kusmana D, Raflianti Y, Mangunwardoyo, W: The Effect of Lovastatin Produced from Aspergillus flavus UICC 360 on Decreasing Cholesterol Level in Blood of Rattusnovergicus L. Sprague Dawley strain. Int. J. Sci. Rese. Publications 2012; 2:1-5.
Snedecor, G. W. and Cochran, W. G: Statistical Methods. 1982; 7th ed. The State University Press American, Iowa.
Lai LS, Tsai TH, et al.: The influence of culturing environments on lovastatin production by Aspergillus terreus in submerged cultures. Enzyme Microb. Technol. 2005; 36:737 – 748.
Osman ME, Khattab OH, Zaghlol GM, El-Hameed RM: Screening for the production of cholesterol lowering drugs (lovastatin) by some fungi. Aus J Basic Appl Sci 2011; 5:698-703.
Atalla MM, Hamed ER and El-Shami AR: Optimization of a culture medium for increased mevinolin production by Aspergillus terreus strain. Malaysian J. Microbiol 2008; 4: 6-10.
Jahromi MF, Liang JB, Ho YW, Mohamad R, Goh YM, Shokryazdan P: Lovastatin production by Aspergillus terreus using agro-biomass as substrate in solid state fermentation. J Biomed Biotechnol. 2012; 1 – 11.
Chanakya P, Latha PM, Manipati Srikanth M: Solid state fermentation for the production of lovastatin by Aspergillus fischerii. Res J Pharm Sci Biotech 2011; 1: 9-13.
Bizukojc M, Pawlak M, Boruta T, Gonciarz J: Effect of pH on biosynthesis of lovastatin and other secondary metabolites by Aspergillus terreus ATCC 20542. J Biotechnol 2012; 162(2 – 3):253 – 261.
Hajjaj H, Niederberger P, Duboc P: Lovastatin biosynthesis by Aspergillus terreus in a chemically defined medium. Appl Environ Microbiol 2001; 67(2):596 – 602.
Xu B, Wang Q, Jia X, Sung C: Enhanced lovastatin production by solid state fermentation of Monascus ruber. Biotechnol Biochem Engg 2005; 10:78-84.
Casas JL, et al.: Production of lovastatin by Aspergillus terreus: effects of the C:N ratio and the principal nutrients on growth and metabolite production. Enzyme and Microbial Technology 2003; 33:270 – 277.
Jia Z, Zhang X, Zhao Y, Cao X: Enhancement of lovastatin production by supplementing polyketide antibiotics to the submerged culture of Aspergillus terreus. Appl Biochem Biotech 2010; 160:2014-2025.
Pie-Lian WEI, Zhi-nan XU, and Pei-Lin CEN: Lovastatin production by Aspergillus terreus in Solid-State fermentation. J Zheijan Univ 2007; 9: 1521-1526.
Kabiri N, Asgary S, Setork M: Lipid lowering by hydroalcoholic extracts of Amaranthus Caudatus L. induces regression of rabbits atherosclerotic lesions. Lipids in Health and Disease 2011; 10:89.
Stapleton PA, Good Will AG, James, ME, Brock RW, Frisbee JC: Hypercholesterolemia and microvascular dysfunction: interventional strategies. Journal of inflammation 2010; 4 7:54.
Raghunath, P M: Study on anti-cholesterolemic activity of lovastatin based on a mice model. International Journal of Comprehensive Research in Biology Sciences 2015; 2(1):41-47.
Frantz E, Menezes HS, Lange KC, Abegg MP, Correa CA, Zangalli L, Vieita JL, Zetter CG: The effect of maternal hypercholesterolemia on the placenta and fetal arteries in rabbits. Acta Cirurgica Brasileira 2012; 27(1):7-12.
Fyiad AA, El-Sayed ST: Effect of Allium Sativum Extract on Serum Lipid and Antioxidant Status in hypercholesterolemic Rabbits. Life Science Journal 2012; 9(3):187-196.
Durak I, et al.: Effects of garlic extract consumption on blood lipid and oxidant/antioxidant parameters in humans with high blood cholesterol. J. Nutr. Biochem. 2004; 15:373 – 377.
Sezer ED, Sozmen EY, Nart D, Onat T: Effect of atorvastatin therapy on oxidantantioxidant status and atherosclerotic plaque formation. Vascular Health and Risk Mangment 2011; 7:333-343.
Daniels TF, Killinger KM, Michal JJ, et al.: Lipoproteins, cholesterol homeostasis and cardiac health. Int. J. Biol. Sci. 2009; 5(5):474-488.
Arhan M, Öztürk HS, Turhan N, Aytac B, Güven MC, Olcay E, Durak I: Hepatic oxidant/antioxidant status in cholesterolfed rabbits: effects of garlic extract. Hepatology Research 2009; 39:70-77.
Sanjay S., Sanjay B., Rupal A., Narasimhacharya A: Lovastatin improves fluoride-induced hypercholesterolemia in Albino Rats. Research report Fluoride 2014; 47(1)69 – 77.
Cooper AJL, Kristal BS: Multiple roles of glutathione in the central nervous system. Biol Chem 1997; 378:793-802.
Piemonte, F. et al.: Glutathione in blood of patients with Friedreich´s ataxia. Eur J Clin Invest 2001; 31:1007-1011.
Lykkesfeldt J: Malondialdehyde as biomarker of oxidative damage to lipids caused by smoking. Clin. Chim. Acta. 2007; 380:50 – 58.
Kumar P, et al.: Simultaneous estimation of statins like pravastain, atorvastatin and simvastatin in bulk and pharmaceutical dosage form by means of High-Performance Liquid Chromatography. Journal of Chemical and Pharmaceutical Research 2013; 5(5):359-364.
Published
How to Cite
Issue
Section
Copyright (c) 2016 Foukia E. Mouafi, Magda M Elkomy, Mostafa M. Abo Elsoud
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Journal of Innovations in Pharmaceutical and Biological Sciences is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Based on a work at